Literature DB >> 2426426

3H-batrachotoxinin-A benzoate binding to voltage-sensitive sodium channels: inhibition by the channel blockers tetrodotoxin and saxitoxin.

G B Brown.   

Abstract

The sodium channel blockers tetrodotoxin (TTX) and saxitoxin (STX) and the channel activator batrachotoxin (BTX) produce their effects by binding to separate and distinct sites on the channel protein. The fact that TTX- and STX-modified sodium channels are blocked to sodium flux has precluded drawing any direct conclusions regarding the effect of TTX/STX on BTX binding based on electrophysiological or 22Na flux measurements. Nevertheless, these sites have been presumed to be non-interacting. In this study, 3H-batrachotoxinin-A benzoate (BTX-B), a tritiated congener of BTX, has been used to provide a direct assessment of these binding interactions. Equilibrium specific binding of 3H-BTX-B to sodium channels in vesicular preparations of mouse brain in the presence of scorpion toxin was measured using a filtration assay procedure. At 25 degrees C both TTX and STX inhibit 3H-BTX-B binding in a concentration-dependent and noncompetitive manner. This inhibition is markedly temperature-dependent, being negligible at 37 degrees C and maximal at 18 degrees C, the lowest temperature investigated. Scatchard analysis of BTX-B binding isotherms at 25 degrees C in the presence and absence of 1 microM TTX revealed that inhibition is due to a 3-fold decrease in the affinity of BTX-B binding with no change in the number of binding sites (Bmax). The concentration dependence for TTX inhibition of both specific 3H-STX and 3H-BTX-B binding is identical, suggesting that inhibition of 3H-BTX-B binding is due to a direct effect of TTX/STX binding at their specific sodium channel site. The channel blockers did not alter the binding of scorpion toxin under these assay conditions, nor did BTX-B affect the binding of 3H-STX.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2426426      PMCID: PMC6568577     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  12 in total

1.  Competitive binding interaction between Zn2+ and saxitoxin in cardiac Na+ channels. Evidence for a sulfhydryl group in the Zn2+/saxitoxin binding site.

Authors:  L Schild; E Moczydlowski
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

Review 2.  Subtype-selective targeting of voltage-gated sodium channels.

Authors:  Steve England; Marcel J de Groot
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

3.  Potentiation by 2,2'-pyridylisatogen tosylate of ATP-responses at a recombinant P2Y1 purinoceptor.

Authors:  B F King; C Dacquet; A U Ziganshin; D F Weetman; G Burnstock; P M Vanhoutte; M Spedding
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.

Authors:  Dieter Scheller; Christoph Ullmer; Reinhard Berkels; Mirella Gwarek; Hermann Lübbert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-14       Impact factor: 3.000

5.  Effects of besipirdine at the voltage-dependent sodium channel.

Authors:  L Tang; C P Smith; F P Huger; S Kongsamut
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  Comparative analysis of the effects of synthetic derivatives of batrachotoxin on sodium currents in frog node of Ranvier.

Authors:  B I Khodorov; E A Yelin; L D Zaborovskaya; M Z Maksudov; O B Tikhomirova; V N Leonov
Journal:  Cell Mol Neurobiol       Date:  1992-02       Impact factor: 5.046

7.  Batrachotoxin-modified sodium channels in planar lipid bilayers. Characterization of saxitoxin- and tetrodotoxin-induced channel closures.

Authors:  W N Green; L B Weiss; O S Andersen
Journal:  J Gen Physiol       Date:  1987-06       Impact factor: 4.086

8.  Synthesis and anticonvulsant activity of new N-phenyl-2-(4-phenylpiperazin-1-yl)acetamide derivatives.

Authors:  Krzysztof Kamiński; Beata Wiklik; Jolanta Obniska
Journal:  Med Chem Res       Date:  2015-03-10       Impact factor: 1.965

9.  Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.

Authors:  Anna Rapacz; Krzysztof Kamiński; Jolanta Obniska; Paulina Koczurkiewicz; Elżbieta Pękala; Barbara Filipek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-02-10       Impact factor: 3.000

10.  Synthesis, Anticonvulsant and Antinociceptive Activity of New Hybrid Compounds: Derivatives of 3-(3-Methylthiophen-2-yl)-pyrrolidine-2,5-dione.

Authors:  Małgorzata Góra; Anna Czopek; Anna Rapacz; Anna Dziubina; Monika Głuch-Lutwin; Barbara Mordyl; Jolanta Obniska
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.